bucindolol hydrochloride

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1993-2018
0119932018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
BACKGROUND Few therapies are available for the safe and effective treatment of atrial fibrillation (AF) in patients with heart… (More)
Is this relevant?
Review
2016
Review
2016
PURPOSE The pharmacology, clinical efficacy, and safety profiles of evolving therapies for the management of chronic heart… (More)
Is this relevant?
Review
2015
Review
2015
Atrial fibrillation (AF) is the most prevalent cardiac arrhythmia and it increases the risk of thromboembolic stroke and death… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
Is this relevant?
Review
2011
Review
2011
β-Adrenoceptor antagonists or β-blockers are a cornerstone of therapy in chronic heart failure (CHF). Bucindolol hydrochloride is… (More)
Is this relevant?
Review
1993
Review
1993
Bucindolol hydrochloride is a phenoxypropanolamine with potent nonselective beta antagonist and mild vasodilatory properties. In… (More)
Is this relevant?